Table II.
Codetection of another respiratory virus with RSV each season∗
| Season 2018-2019 | Season 2019-2020 | Season 2020-2021 | |
|---|---|---|---|
| Total cases positive for RSV | 1036 | 1162 | 143 |
| Codetection of another respiratory virus | 354 (34.2%) | 368 (31.7%) | 50 (34.9%) |
| Rhinovirus/enterovirus | 157 (15.2%) | 148 (12.7%)† | 29 (20.3%) |
| Influenza | 30 (2.9%) | 41 (3.5%) | 0 (0%) |
| Coronavirus | 96 (9.3%) | 108 (9.3%) | 11 (7.7%) |
| Parainfluenza | 19 (1.8%)† | 13 (1.1%)† | 8 (5.6%) |
| Human metapneumovirus | 13 (1.3%) | 6 (0.5%) | 0 (0%) |
| Adenovirus | 67 (6.5%) | 87 (7.5%) | 13 (9.1%) |
| SARS-CoV-2 | 0 (0%) | 0 (0%) | 1 (1.6%) |
RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Children had coinfections with >1 virus.
Comparator season proportion significantly different from the 2020 to the 2021 season (P < .05).